AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Overview of a yearly tax planning approach for index fund losses, detailing steps to track opportunities, document losses, and optimize filings.
19,656 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
SpaceX headlines grab attention, but smart investors look for durable earnings growth in established aerospace player...
MicroStrategy announces a sweeping Digital Credit Capital Framework that reshapes how it funds Bitcoin purchases and ...
A federal judge granted Alibaba a temporary reprieve from the Defense Department lobbying ban as she weighs the compa...
Class-action settlements can bring real money to legitimate claimants, but fraudsters have tried to exploit the syste...
Bitcoin climbs past $64,000 as spot BTC ETF inflows resume, highlighting a price-driven rebound that may outpace inst...
A high-stakes pivot: the team behind ethereum's institutional privacy push launches EthSystems, a for-profit venture ...
Crypto traders increasingly rely on AI to sift signals and manage portfolios. This gpt-5.6 fable review: which guide ...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
ARMLS moves to an independent board with an advisory council to keep practitioner voices in governance. The transitio...
A Florida appeals court ruled that undisbursed funds from a reverse mortgage line of credit are protected by the home...
PayPal faced a liquidity cliff that could have erased the company. This report traces how a crisis, a bold offsite, a...